Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oxford GlycoSciences Plc -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (291)	12/28/2002 5:51:08 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 469

patft.uspto.gov; We claim: 1. A computer-controlled device for removing a selected portion of a polyacrylamide gel, the device comprising: (a) a locating mechanism for defined location of the gel; (b) an excision component; and (c) an x,y coordinate locating mechanism capable of driving the excision component to perform x and y movements, wherein the device is capable of removing the selected portion of the polyacrylamide gel under remote computer control.

To: scaram(o)uche who wrote (291)	12/28/2002 7:22:52 PM
From: nigel bates	Respond to of 469

A number of companies are using technology that's probably in violation of our intellectual property.... We're in discussions, saying to them, "Please pay us a royalty Didn't they sell a license to Geneprot for £1m ? I didn't see anything about further royalty payments, so unless the price has gone up...